Healthcare Licensing with focus on Generics Market: Global Market Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025

Report code: BEMRC 3126 | Report Format: | 09-Jul-2019 | Number of pages: 208 | Post Publisher:BEMRC

 

“The detailed market intelligence report on the Global Healthcare Licensing with focus on Generics Market applies the most effective of each primary and secondary analysis to weighs upon the competitive landscape and also the outstanding market players expected to dominate Global Healthcare Licensing with focus on Generics Market place for the forecast 2019– 2025.

Scope Of The Report:

Report evaluates the growth rate and the Market value based on Market dynamics, growth inducing factors. The complete knowledge is based on latest industry news, opportunities and trends. The report contains a comprehensive Market analysis and vendor landscape in addition to a SWOT analysis of the key vendors.

Geographically, this report split global into several key Regions, revenue (Million USD) The geography (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa) focusing on key countries in each region. It also covers market drivers, restraints, opportunities, challenges, and key issues in Global Healthcare Licensing with focus on Generics Market.

Key Benefits for Healthcare Licensing with focus on Generics Market Reports

  • Global market report covers in-depth historical and forecast analysis.
  • Global market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level.
  • Global market report helps to identify opportunities in market place.
  • Global market report covers extensive analysis of emerging trends and competitive landscape.

Healthcare Licensing with focus on Generics Market Segmentation:

By Region

  • North America

o U.S.

o Canada

o Mexico

  • Europe

o UK

o France

o Germany

o Russia

o Rest of Europe

  • Asia-Pacific

o China

o South Korea

o India

o Japan

o Rest of Asia-Pacific

  • LAMEA

o Latin America

o Middle East

o Africa

Healthcare Licensing with focus on Generics Market Key Players:

  • Catalent, Inc.
  • Cipla Limited
  • Depomed Inc.
  • Eisai Co. Ltd.
  • Amneal Pharmaceuticals, Inc.
  • ANI Pharmaceuticals, Inc.
  • Armas Pharmaceuticals Inc.
  • AstraZeneca plc
  • Aucta Pharmaceuticals Inc.
  • Aurobindo Pharma Limited
  • Others

This comprehensive report will provide:

  • Enhance your strategic decision making
  • Assist with your research, presentations and business plans
  • Show which emerging market opportunities to focus on
  • Increase your industry knowledge
  • Keep you up-to-date with crucial market developments
  • Allow you to develop informed growth strategies
  • Build your technical insight
  • Illustrate trends to exploit
  • Strengthen your analysis of competitors
  • Provide risk analysis, helping you avoid the pitfalls other companies could make
  • Ultimately, help you to maximize profitability for your company.

Our Market Research Solution Provides You Answer to Below Mentioned Question:

  • Which are the driving factors responsible for the growth of market?
  • Which are the roadblock factors of this market?
  • What are the new opportunities, by which market will grow in coming years?
  • What are the trends of this market?
  • Which are main factors responsible for new product launch?
  • How big is the global & regional market in terms of revenue, sales and production?
  • How far will the market grow in forecast period in terms of revenue, sales and production?
  • Which region is dominating the global market and what are the market shares of each region in the overall market in 2017?
  • How will each segment grow over the forecast period and how much revenue will these segment account for in 2025?
  • Which region has more opportunities?”

 

 

“Table of Content

  1. Chapter – Report Methodology

1.1. Research Process

1.2. Primary Research

1.3. Secondary Research

1.4. Market Size Estimates

1.5. Data Triangulation

1.6. Forecast Model

1.7. USP’s of Report

1.8. Report Description

  1. Chapter – Global Healthcare Licensing with focus on Generics Market Overview: Qualitative Analysis

2.1. Market Introduction

2.2. Executive Summary

2.3. Global Healthcare Licensing with focus on Generics Market Classification

2.4. Market Drivers

2.5. Market Restraints

2.6. Market Opportunity

2.7. Healthcare Licensing with focus on Generics Market: Trends

2.8. Porter’s Five Forces Analysis

2.8.1. Bargaining Power of Suppliers

2.8.2. Bargaining Power of Consumers

2.8.3. Threat of New Entrants

2.8.4. Threat of Substitute Product and Services

2.8.5. Competitive Rivalry within the Industry

2.9. Market Attractiveness Analysis

2.9.1. Market Attractiveness Analysis by Segmentation

2.9.2. Market Attractiveness Analysis by Region

  1. Chapter – Global Healthcare Licensing with focus on Generics Market Overview: Quantitative Analysis

3.1. Global Healthcare Licensing with focus on Generics Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2014- 2025

3.2. Global Healthcare Licensing with focus on Generics Market Revenue Market Share (%), 2014- 2025

3.3. Global Healthcare Licensing with focus on Generics Market Sales (Number of Units), Market Share (%) and Growth Rate (%), 2014- 2025

3.4. Global Healthcare Licensing with focus on Generics Market Sales Market Share (%), 2014- 2025

  1. Chapter – Global Healthcare Licensing with focus on Generics Market Analysis: By Manufacturer

4.1. Global Healthcare Licensing with focus on Generics Market Revenue (USD Million), by Manufacturer, 2014 – 2025

4.2. Global Healthcare Licensing with focus on Generics Market Share (%), by Manufacturer, 2018

4.3. Global Healthcare Licensing with focus on Generics Market Sales (Number of Units), by Manufacturer, 2014 – 2025

4.4. Global Healthcare Licensing with focus on Generics Market Share (%), by Manufacturer, 2018

4.5. Global Healthcare Licensing with focus on Generics Market Price (USD/Unit), by Manufacturer, 2014 – 2025

4.6. Global Healthcare Licensing with focus on Generics Market Revenue Growth Rate (%), by Manufacturer, 2014 – 2025

4.7. Merger & Acquisition

4.8. Collaborations and Partnership

4.9. New Product Launch

  1. Chapter –Healthcare Licensing with focus on Generics Market: Regional Analysis

5.1. North America

5.1.1. North America Healthcare Licensing with focus on Generics Market Revenue (USD Million) and Growth Rate (%), 2014 – 2025.

5.1.2. North America Healthcare Licensing with focus on Generics Market Revenue (USD Million) By Country, 2014 – 2025.

5.1.3. North America Healthcare Licensing with focus on Generics Revenue Market Share (%) By Country, 2014 – 2025.

5.1.4. North America Healthcare Licensing with focus on Generics Market Revenue (USD Million) and Growth Rate, By Market Segmentation, 2014 – 2025.

5.1.5. North America Healthcare Licensing with focus on Generics Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2025.

5.1.6. North America Healthcare Licensing with focus on Generics Market Sales (Number of Units) and Growth Rate (%), 2014 – 2025.

5.1.7. North America Healthcare Licensing with focus on Generics Market Sales (Number of Units) By Country, 2014 – 2025.

5.1.8. North America Healthcare Licensing with focus on Generics Sales Market Share (%) By Country, 2014 – 2025.

5.1.9. North America Healthcare Licensing with focus on Generics Market Sales (Number of Units) and Growth Rate, By Market Segmentation, 2014 – 2025.

5.1.10. North America Healthcare Licensing with focus on Generics Market Sales (Number of Units), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2025.

5.2. Europe

5.3. Asia Pacific

5.4. Latin America

5.5. Middle East & Africa

  1. Chapter – Company Profiles

6.1. Catalent, Inc.

6.1.1. Overview

6.1.2. Financials

6.1.3. Product portfolio

6.1.4. Healthcare Licensing with focus on Generics Market Revenue (USD Million) and Market Share (%), 2014 – 2018

6.1.5. Healthcare Licensing with focus on Generics Sales Market Share (%), 2014 – 2018

6.1.6. Business strategy

6.1.7. Recent developments

6.2. Cipla Limited

6.3. Depomed Inc.

6.4. Eisai Co. Ltd.

6.5. Amneal Pharmaceuticals, Inc.

6.6. ANI Pharmaceuticals, Inc.

6.7. Armas Pharmaceuticals Inc.

6.8. AstraZeneca plc

6.9. Aucta Pharmaceuticals Inc.

6.10. Aurobindo Pharma Limited

6.11. Aurobindo Pharma USA Inc.

6.12. Bausch Health Companies Inc.

6.13. Beximco Pharmaceuticals Ltd

6.14. AbbVie Inc.

6.15. Catalyst Pharmaceuticals Inc.

6.16. Celon Pharma S.A.

6.17. Actavis Laboratories FL, Inc.

6.18. CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd

6.19. Alvogen Korea Co Ltd

6.20. Dr. Reddy’s Laboratories Ltd.

6.21. American Regent Inc

6.22. Elite Pharmaceuticals, Inc.

6.23. Endo International plc

6.24. Entasis Therapeutics Inc

6.25. EPI Health, LLC

6.26. Ferring Pharmaceuticals

6.27. G&W Laboratories, Inc.

6.28. Galaxy Bio, Inc.

6.29. Gilead Sciences, Inc.

6.30. Glenmark Pharmaceuticals Europe Ltd.

6.31. Glenmark Pharmaceuticals S.A.

6.32. Glenmark Pharmaceuticals, Inc., USA

6.33. Global Antibiotic Research & Development Partnership

6.34. Grand River Aseptic Manufacturing Inc.

6.35. Granules India Ltd

6.36. Hikma Pharmaceuticals plc

6.37. Iconovo AB

6.38. IDT Australia, Ltd.

6.39. Impression Healthcare Limited

6.40. Intellipharmaceutics International Inc.

6.41. Intercept Pharmaceuticals, Inc.

6.42. Jerome Stevens Pharmaceuticals, Inc

6.43. Jiangsu Hengrui Medicine Co., Ltd.

6.44. Lannett Company, Inc.

6.45. Mallinckrodt PLC

6.46. Mawdsley-Brooks & Co. Ltd.

6.47. Mayne Pharma Group Ltd

6.48. McKesson Corporation

6.49. Medicines Patent Pool

6.50. Merck & Co. Inc.

6.51. Mithra Pharmaceuticals S.A.

6.52. MSN Laboratories Pvt ltd

6.53. Natco Pharma

6.54. Neo Health (OTC) Pty Ltd

6.55. Nichi-Iko Pharmaceutical Co., Ltd.

6.56. Novartis AG

6.57. Oakrum Pharma, LLC

6.58. Orifarm Group A/S

6.59. Panacea Biotec Ltd

6.60. PDL BioPharma, Inc.

6.61. Zai Lab Limited

6.62. Perrigo Company plc

6.63. Piedmont Animal Health LLC

6.64. West-Ward Pharmaceutical Corp.

6.65. Reliance Life Sciences Private Limited

6.66. Resolution Chemicals

6.67. Rite Aid Corporation

6.68. Waverley Pharma Inc.

6.69. Vectura Group plc

6.70. Shilpa Medicare Limited

6.71. Sol Gel Technologies Ltd

6.72. Spear Pharmaceuticals, Inc

6.73. Sumitomo Dainippon Pharma Co Ltd.

6.74. Sun Pharmaceutical Industries Ltd.

6.75. SunGen Pharma, LLC

6.76. Takeda Pharma U.S.A Inc

6.77. UPMC Health Plan

6.78. Sandoz Inc

6.79. Rivopharm SA

6.80. Prasco Laboratories

6.81. Perrigo Animal Health

6.82. Others

  1. Chapter – Market Research and Findings”

 

  • AbbVie Inc.
  • Actavis Laboratories FL, Inc.
  • Alvogen Korea Co Ltd
  • American Regent Inc
  • Amneal Pharmaceuticals, Inc.
  • ANI Pharmaceuticals, Inc.
  • Armas Pharmaceuticals Inc.
  • AstraZeneca plc
  • Aucta Pharmaceuticals Inc.
  • Aurobindo Pharma Limited
  • Aurobindo Pharma USA Inc.
  • Bausch Health Companies Inc.
  • Beximco Pharmaceuticals Ltd
  • Catalent, Inc.
  • Catalyst Pharmaceuticals Inc.
  • Celon Pharma S.A.
  • Cipla Limited
  • CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd
  • Depomed Inc.
  • Dr. Reddy’s Laboratories Ltd.
  • Eisai Co. Ltd.
  • Elite Pharmaceuticals, Inc.
  • Endo International plc
  • Entasis Therapeutics Inc
  • EPI Health, LLC
  • Ferring Pharmaceuticals
  • G&W Laboratories, Inc.
  • Galaxy Bio, Inc.
  • Gilead Sciences, Inc.
  • Glenmark Pharmaceuticals Europe Ltd.
  • Glenmark Pharmaceuticals S.A.
  • Glenmark Pharmaceuticals, Inc., USA
  • Global Antibiotic Research & Development Partnership
  • Grand River Aseptic Manufacturing Inc.
  • Granules India Ltd
  • Hikma Pharmaceuticals plc
  • Iconovo AB
  • IDT Australia, Ltd.
  • Impression Healthcare Limited
  • Intellipharmaceutics International Inc.
  • Intercept Pharmaceuticals, Inc.
  • Jerome Stevens Pharmaceuticals, Inc
  • Jiangsu Hengrui Medicine Co., Ltd.
  • Lannett Company, Inc.
  • Mallinckrodt PLC
  • Mawdsley-Brooks & Co. Ltd.
  • Mayne Pharma Group Ltd
  • McKesson Corporation
  • Medicines Patent Pool
  • Merck & Co. Inc.
  • Mithra Pharmaceuticals S.A.
  • MSN Laboratories Pvt ltd
  • Natco Pharma
  • Neo Health (OTC) Pty Ltd
  • Nichi-Iko Pharmaceutical Co., Ltd.
  • Novartis AG
  • Oakrum Pharma, LLC
  • Orifarm Group A/S
  • Panacea Biotec Ltd
  • PDL BioPharma, Inc.
  • Perrigo Animal Health
  • Perrigo Company plc
  • Piedmont Animal Health LLC
  • Prasco Laboratories
  • Reliance Life Sciences Private Limited
  • Resolution Chemicals
  • Rite Aid Corporation
  • Rivopharm SA
  • Sandoz Inc
  • Shilpa Medicare Limited
  • Sol Gel Technologies Ltd
  • Spear Pharmaceuticals, Inc
  • Sumitomo Dainippon Pharma Co Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • SunGen Pharma, LLC
  • Takeda Pharma U.S.A Inc
  • UPMC Health Plan
  • Vectura Group plc
  • Waverley Pharma Inc.
  • West-Ward Pharmaceutical Corp.
  • Zai Lab Limited